Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.

20:49 12/12/2025

Meipu Medical (301033.SZ) announced that the company has received notification letters from its shareholders Shenzhen Kaiying and Fengyan Fund regarding their plans to reduce their shareholdings. Shenzhen Kaiying plans to reduce no more than 150,000 shares, which is equivalent to 0.2237% of the total share capital of the company; Fengyan Fund plans to reduce no more than 668,100 shares, accounting for 0.9964% of the current share capital of the company (1.0000% excluding the shares held in the company's repurchase special account).

Medprin Regenerative Medical Technologies (301033.SZ) announcement, the company has received notification letters from shareholders Shenzhen Kaiying and Fengyan Fund regarding their plans to reduce their shareholding. Shenzhen Kaiying plans to reduce no more than 150,000 shares, or 0.2237% of the total share capital of the company; Fengyan Fund plans to reduce no more than 668,100 shares, accounting for 0.9964% of the current share capital of the company (excluding the shares held in the company's repurchase account, the percentage is 1.0000%).

CIFI HOLD GP(00884) and its subsidiaries Spectron and LMR have entered into a three-year term option trading agreement, as well as sales and swap transactions.

Chongqing Sokon Industry Group Stock (09927): Yang Yanding nominated as a non-executive director candidate

WENYE GROUP (01802) received resumption guidance from the Hong Kong Stock Exchange and will continue the suspension.

CIFI HOLD GP(00884) and its subsidiaries Spectron and LMR have entered into a three-year term option trading agreement, as well as sales and swap transactions.

Chongqing Sokon Industry Group Stock (09927): Yang Yanding nominated as a non-executive director candidate

WENYE GROUP (01802) received resumption guidance from the Hong Kong Stock Exchange and will continue the suspension.